London [UK]/Mumbai (Maharashtra) [India], March 11 (ANI/PRNewswire): Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformite Europeenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management.